Natural Health Trends financials
$1.03+4.04%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $39.8M | $43.0M | $43.9M | $49.1M | $60.0M | $62.1M | $77.6M | $191.9M | $197.6M | $287.7M |
| Gross profit | $29.3M | $31.8M | $32.7M | $36.5M | $45.0M | $45.1M | $57.5M | $152.5M | $158.9M | $232.8M |
| Gross margin | 73.5% | 74.0% | 74.6% | 74.2% | 75.0% | 72.6% | 74.1% | 79.5% | 80.4% | 80.9% |
| Operating income | -$1.8M | -$1.3M | -$1.7M | -$270.0K | $1.6M | $669.0K | -$7.0M | $33.7M | $43.1M | $64.1M |
| Net income | -$882.0K | $572.0K | $568.0K | $313.0K | $1.1M | $843.0K | -$5.6M | $31.0M | $23.6M | $55.1M |
| Net margin | −2.2% | 1.3% | 1.3% | 0.6% | 1.8% | 1.4% | −7.2% | 16.2% | 11.9% | 19.1% |
| Diluted EPS | $-0.08 | $0.05 | $0.05 | $0.03 | $0.09 | $0.07 | $-0.52 | $2.74 | $2.09 | $4.83 |
| EBITDA | -$1.7M | -$1.2M | -$1.5M | -$66.0K | $1.9M | $1.1M | -$4.9M | $34.2M | $43.6M | $64.5M |
| Operating cash flow | -$6.0M | -$3.4M | -$4.3M | -$4.9M | $1.0M | $1.9M | -$18.6M | $29.7M | $26.6M | $53.2M |
| Free cash flow | -$6.1M | -$3.4M | -$4.3M | -$5.0M | $791.0K | $1.7M | -$18.8M | $29.5M | $26.3M | $52.3M |
| Diluted shares | 11.5M | 11.5M | 11.5M | 11.4M | 11.4M | 11.4M | 10.9M | 11.3M | 11.3M | 11.4M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.8M | $13.5M | $56.2M | $69.7M | $83.8M | $92.4M |
| Short-term investments | $22.1M | $30.4M | $0.00 | $0.00 | — | — |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $38.4M | $55.4M | $69.1M | $82.8M | $98.4M | $105.9M |
| Total liabilities | $15.0M | $22.5M | $27.5M | $32.7M | $38.9M | $38.2M |
| Shareholders' equity | $23.4M | $32.9M | $41.6M | $50.2M | $59.5M | $67.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology